update desk

Beilinson confab debates pros and cons of AI for healthcare industry

Legal and ethical implications and liability issues among the subjects discussed.

Beilinson Hospital in Petach Tikvah hosts the Medical AI Roadmap Conference. Credit: Koko/Beilinson Hospital.
Beilinson Hospital in Petach Tikvah hosts the Medical AI Roadmap Conference. Credit: Koko/Beilinson Hospital.

Beilinson Hospital in Petach Tikva hosted the Medical AI Roadmap Conference recently, bringing together Israel’s leading doctors, academics, scientists and entrepreneurs to discuss the impact of artificial intelligence (AI) on the healthcare industry.

Session topics focused on how AI can be integrated with medical practice and the potential advantages and pitfalls, with presentations discussing how this combination impacts physicians and healthcare providers. Other subjects addressed included the legal and ethical implications of using AI and liability issues that can arise. Discussions covered specialties such as cardiology, neurology oncology, ophthalmology and medical imaging.

“We are approaching a pivotal moment in medicine as AI and machine learning come to the fore and the medical community must discuss its impact and potential ramifications,” said Beilinson Hospital Director of Cardiology Center Prof. Ran Kornowski, who led the conference.

“This year’s event brings together the brightest minds from Israel and based on the overwhelming support it has received, we hope that this will become an annual event and that we will be able to include leaders in these fields from other countries next year,” he added.

Beilinson is an 1,100-bed hospital staffed by a team of 7,500 medical and support professionals. It has 36 operation rooms and performs the majority of organ transplants in Israel.

You have read 3 articles this month.
Register to receive full access to JNS.

Just before you scroll on...

Israel is at war.

JNS is combating the stream of misinformation on Israel with real, honest and factual reporting. In order to deliver this in-depth, unbiased coverage of Israel and the Jewish world, we rely on readers like you.

The support you provide allows our journalists to deliver the truth, free from bias and hidden agendas. Can we count on your support?

Every contribution, big or small, helps JNS.org remain a trusted source of news you can rely on.

Become a part of our mission by donating today
Topics
Comments
Thank you. You are a loyal JNS Reader.
You have read more than 10 articles this month.
Please register for full access to continue reading and post comments.
Never miss a thing
Get the best stories faster with JNS breaking news updates